Social anxiety disorder

Med Clin North Am. 2001 May;85(3):711-33. doi: 10.1016/s0025-7125(05)70337-0.

Abstract

In 1990s, it was found that GSAD is more common, more disabling, and more chronic than previously realized. For the first time, there are good data about a range of effective treatment options that can offer these patients substantial relief and protection from their disability.

Publication types

  • Review

MeSH terms

  • Anti-Anxiety Agents / therapeutic use
  • Behavior Therapy
  • Benzodiazepines
  • Chronic Disease
  • Combined Modality Therapy
  • Comorbidity
  • Diagnosis, Differential
  • Humans
  • Interview, Psychological
  • Mass Screening / methods
  • Models, Psychological
  • Phobic Disorders / classification
  • Phobic Disorders / diagnosis*
  • Phobic Disorders / epidemiology
  • Phobic Disorders / etiology
  • Phobic Disorders / therapy*
  • Prevalence
  • Psychiatric Status Rating Scales
  • Selective Serotonin Reuptake Inhibitors / therapeutic use
  • United States / epidemiology

Substances

  • Anti-Anxiety Agents
  • Serotonin Uptake Inhibitors
  • Benzodiazepines